Kavalactones exert their effects by interacting with various neurotransmitter systems in the brain, particularly the GABAergic system. They enhance the binding of GABA, a primary inhibitory neurotransmitter, leading to sedative and relaxing effects. This mode of action is similar to that of benzodiazepines, albeit through a different binding site, which accounts for their anxiolytic properties.
